Centers for Disease Control and Prevention - ERA

Description

Purpose This FOA is intended to support research on lupus through a longitudinal study designed to follow an established, US-based., population-based cohort with lupus (systemic lupus erythematosus {SLE} and skin lupus) of all ages to determine over time: o The treatment, health care access, and natural history (severity, morbidity, mortality, etc.) of cohort members, o Factors (including genetic and other biological factors such as antibody levels) associated with these outcomes, and o The above by categories of research interest (e.g., age, gender, race/ethnic group). Knowledge of such information for lupus, which is associated with strong age/sex/race disparities and has had little public health research, can help identify missed opportunities for better treatment, help identify new disease phenotypes based on progression of disease, and help identify factors associated with progression that may play a role in secondary and tertiary prevention. Foreign Organizations Foreign Organizations are eligible to apply. Foreign components of U.S. Organizations are eligible to apply

Who can apply

• Others

Contact

CDC Procurement and Grants Office <br/>(PGO) Technical Information Management Section (TIMS) <br/>Phone: 770-488-2700 <br/>E-mail: pgotim@cdc.gov <br/>
pgotim@cdc.gov